Germany Prostate Cancer Diagnostic and Therapeutic Market Industry Analysis, Size, Share, Growth, Trends and Forecast 2019 - 2025

Germany prostate cancer market is forecast to grow at a CAGR of 11.5% during the forecast period. The high prevalence of prostate cancer in the country is one of the major factors for the demand for prostate cancer diagnostics services and therapeutics. As per the World Health Organization, around 63,000 new cases of prostate cancer were registered in 2018. Cancer has the highest share of all cancer among men in the country with around 19% of the overall cases. The 5-year prevalence in the country due to prostate cancer is around 233,000 in 2018.

Get Sample Copy of Germany Prostate Cancer Diagnostic and Therapeutic Market at: https://www.omrglobal.com/request-sample/germany-prostate-cancer-diagnostic-therapeutic-market

The companies which are contributing significantly in the market include Abbott Laboratories, AbbVie Products, LLC, AstraZeneca PLC, Bayer AG, Bristol-Myers Squibb Co., GlaxoSmithKline PLC, Johnson & Johnson, Pfizer Inc., Siemens Healthcare AG and others.

Moreover, the increasing geriatric population, the presence of highly specialized urologists for prostate cancer treatment are contributing to the growth of the market. Around 90% of the German population is insured by the statutory health insurance (SHI). Regardless of the type of health insurance, all beneficiaries have access to an outpatient physician and non-physician services, hospital care, rehabilitation, dental care, prescription drugs, medical supplies and long-term nursing care.

For More Information, get A full report of Germany Prostate Cancer Diagnostic and Therapeutic is available at: https://www.omrglobal.com/industry-reports/germany-prostate-cancer-diagnostic-therapeutic-market

The presence of renowned clinics and treatment centers in the country is another major factor for the growth of the market as it is augmenting medical tourism. Martini Klinik is one of the largest prostate cancer clinics all across the globe that caters to more than 5,000 outpatient cases and 2,400 surgical cases seen every year. The presence of highly skilled doctors and urologists in Germany attracts many patients to the country for receiving treatment procedures. For instance, each surgeon at Martini Klinik conducts between 200 and 300 procedures per year.

Germany prostate cancer diagnostic and therapeutic market has been studied on the basis of diagnostic techniques and therapeutics. By diagnosis technique, prostate biopsy is expected to hold a major market share during the forecast period. By therapeutics, chemotherapy is expected to have a major market share in the country. The market players are considerably contributing to the market growth by the adoption of various growth strategies including new product launch, merger, and acquisition, collaborations with government, and technological advancements to stay competitive in the market.

Germany Prostate Cancer Diagnostic and Therapeutic Market Segmentation

Germany Prostate Cancer Diagnostic and Therapeutic Market by Diagnostic Techniques

o Prostate-Specific Antigen Test (PSA)
o Digital Rectal Examination
o Prostate Biopsy
o Imaging Techniques

Germany Prostate Cancer Diagnostic and Therapeutic Market by Therapeutics

o Hormonal Therapy
o Chemotherapy
o Immunotherapy
o Radiation Therapy
o Targeted Therapy
o Surgery

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/germany-prostate-cancer-diagnostic-therapeutic-market

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

For More Information, Visit https://www.omrglobal.com/

This release was published on openPR.